| Literature DB >> 23874098 |
Rikuei Hirosawa1, Jin Narumoto, Yuki Sakai, Seiji Nishida, Takuya Ishida, Takashi Nakamae, Yuichi Takei, Kenji Fukui.
Abstract
BACKGROUND: Near-infrared spectroscopy has helped our understanding of the neurobiological mechanisms of psychiatric disorders and has advantages including noninvasiveness, lower cost, and ease of use compared with other imaging techniques, like functional magnetic resonance imaging. The verbal fluency task is the most common and well established task used to assess cognitive activation during near-infrared spectroscopy. Recent functional neuroimaging studies have shown that the orbitofrontal cortex and other brain regions, including the dorsolateral prefrontal cortex, may play important roles in the pathophysiology of obsessive-compulsive disorder (OCD). This study aimed to evaluate hemodynamic responses in the dorsolateral prefrontal cortex in patients with OCD using near-infrared spectroscopy during the verbal fluency task and to compare these with dorsolateral prefrontal cortex responses in healthy controls.Entities:
Keywords: dorsolateral prefrontal cortex; functional neuroimaging; near-infrared spectroscopy; obsessive-compulsive disorder; prefrontal hemodynamic response; verbal fluency task
Year: 2013 PMID: 23874098 PMCID: PMC3713899 DOI: 10.2147/NDT.S45402
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Clinical characteristics of patients with obsessive-compulsive disorder and healthy controls
| Patients with OCD (n = 20)
| Healthy controls (n = 20)
| Statistics | ||
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| Gender, M/F | 9/11 | 8/12 | χ2 = 0.10 | 0.75 |
| Age, years | 38.1 ± 10.9 | 37.1 ± 8.4 | 0.73 | |
| Total Y-BOCS score | 19.6 ± 8.2 | NA | NA | NA |
| MOCI | 15.5 ± 5.8 | 4.3 ± 3.5 | <0.001 | |
| HDRS score | 2.0 ± 2.4 | NA | NA | NA |
| HARS score | 2.6 ± 2.7 | NA | NA | NA |
| Duration of illness, months | 104.2 ± 91.0 | NA | NA | NA |
| IQ | 105.1 ± 10.3 | 103.8 ± 8.2 | 0.66 |
Abbreviations: F, female; M, male; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; MOCI, Maudsley Obsessive-Compulsive Inventory; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; NA, not applicable; IQ, intelligence quotient; OCD, obsessive-compulsive disorder; SD, standard deviation.
Figure 1Grand-average waveforms of changes in oxygenated hemoglobin concentration in controls (red line) and the group with obsessive-compulsive disorder (blue line). The areas enclosed with red frames show the regions of interest. The x-axis shows time course (s) and the y-axis shows the change in oxygenated hemoglobin concentration (mM • cm). Grand-average waveforms of changes in oxygenated hemoglobin concentration in healthy controls increased during the task period, but did not increase markedly in the obsessive-compulsive disorder group.
Abbreviation: CH, channel.
Figure 2Localization matrices mapped over a standard brain template. Areas shown in yellow represent matrix of guidance channels. (A) Matrix of guidance in which areas shown in orange represent regions of interest. (B) Patients with obsessive-compulsive disorder had significantly smaller changes in oxygenated hemoglobin concentration than controls at channel 18 (orange), localized near the right lateral prefrontal region.
Clinical characteristics of patients with obsessive-compulsive disorder
| Case | Gender | Age, years | Total Y-BOCS score | MOCI | HDRS score | HARS score | DUI | IQ | VF | Equivalent dose, mg/day (imipramine, diazepam, chlorpromazine) | Consultation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 40 | 31 | 21 | 3 | 1 | 144 | 120.3 | 15 | 0 | I |
| 2 | M | 52 | 18 | 18 | 1 | 1 | 96 | 97.1 | 11 | Sertraline 100 (150) | I |
| 3 | F | 52 | 18 | 10 | 1 | 1 | 144 | 129 | 16 | Fluvoxamine 100 (100) | D |
| 4 | M | 41 | 28 | 24 | 2 | 3 | 96 | 100 | 14 | 0 | D |
| 5 | F | 46 | 32 | 19 | 9 | 11 | 156 | 94.2 | 12 | 0 | I |
| 6 | M | 51 | 9 | 6 | 1 | 1 | 68 | 117.4 | 13 | Paroxetine 40 (150), | I |
| 7 | M | 23 | 9 | 14 | 3 | 4 | 18 | 97.1 | 8 | 0 | D |
| 8 | F | 38 | 18 | 15 | 3 | 5 | 144 | 105.8 | 9 | 0 | D |
| 9 | F | 57 | 33 | 24 | 6 | 4 | 324 | 111.6 | 8 | Clomipramine 150 (187.5) | I |
| 10 | F | 27 | 24 | 20 | 1 | 0 | 72 | 102.9 | 9 | Fluvoxamine 100 (100) | D |
| 11 | F | 44 | 31 | 18 | 3 | 3 | 132 | 88.4 | 11 | Paroxetine 50 (187.5) | I |
| 12 | F | 47 | 12 | 12 | 1 | 3 | 36 | 108.7 | 14 | 0 | D |
| 13 | F | 42 | 17 | 13 | 0 | 0 | 312 | 111.6 | 18 | Paroxetine 30 (112.5) | D |
| 14 | F | 27 | 20 | 20 | 0 | 0 | 106 | 114.5 | 12 | Paroxetine 20 (75) | I |
| 15 | M | 19 | 15 | 18 | 0 | 0 | 48 | 91.3 | 11 | Clomipramine 150 (187.5) | I |
| 16 | M | 34 | 18 | 18 | 5 | 6 | 12 | 108 | 10 | Paroxetine 30 (112.5) | D |
| 17 | M | 29 | 14 | 10 | 0 | 1 | 3 | 97.1 | 12 | Paroxetine 30 (112.5) | I |
| 18 | M | 33 | 4 | 2 | 0 | 0 | 156 | 108.7 | 11 | Clomipramine 75 (93.75) | I |
| 19 | M | 34 | 22 | 17 | 1 | 4 | 4 | 102.9 | 19 | Paroxetine 50 (187.5) | I |
| 20 | F | 26 | 18 | 10 | 0 | 3 | 12 | 100 | 8 | 0 | I |
Abbreviations: F, female; M, male; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; MOCI, Maudsley Obsessive-Compulsive Inventory; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; DUI, duration of illness; IQ, intelligence quotient; VF, verbal fluency scores; D, directly consulted; I, introduced.
Figure 3Mean z-score during the verbal fluency task in the right dorsolateral prefrontal cortex (channel 18). The vertical bars represent the standard error. The oxygenated hemoglobin concentration in patients with obsessive-compulsive disorder at the right dorsolateral prefrontal cortex was significantly smaller than that in controls (P < 0.05).
Abbreviations: DLPFC, dorsolateral prefrontal cortex; HC, healthy controls; OCD, obsessive-compulsive disorder; CH, Channel.